ATH 11.1% 0.5¢ alterity therapeutics limited

Another abstract in AAN virtual meeting

  1. 2,698 Posts.
    lightbulb Created with Sketch. 941
    https://n.neurology.org/content/94/15_Supplement/4157

    This an animal study but it is about ATH434. The analyses are not yet totally completed. The other interesting thing is that there are co-authors from Austria (Refolo and Stefanova), Sweden ( Zetterberg, who was also in the PBT2 Euro-study group), Heslegrave from London among our Stamler.

    My point is that something "international" is happening with ATH434. This is good when there is a need to get many international study places for phase 2, perhaps.





 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $177.1K 43.22M

Buyers (Bids)

No. Vol. Price($)
5 6530000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 61097700 52
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 12.5 %)
Open High Low Volume
0.4¢ 0.5¢ 0.4¢ 23124792
Last updated 15.14pm 19/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.